VALNEVA
Declaration of shares and voting rights
December 31, 2023
__________________________________________________________________________________________
Company name: VALNEVA
Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)
Regulated market of Euronext Paris – Compartment B
Declaration date: January 5, 2024
| Number of shares composing the share capital of Valneva |
Total number of voting rights including suspended voting rights* | Description of the change | Date on which this change was recognized | Total number of voting rights excluding suspended voting rights** |
| 138,912,142
ordinary shares with a par value of €0.15 each |
162,189,321 | Double voting rights granted on 10,783 ordinary shares
|
Between December 6 & December 27, 2023 | 162,064,999 |
___________________________
* Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.
** Net (or exercisable at a General Meeting) voting rights.
Attachment
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…
Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…